Enclomiphene — Indexed Studies

A Novel Three-Dimension Printed Individualized Curved-Needle-Based Interstitial Brachytherapy for Re-Irradiation in Uterine Fundus-Involving Recurrent Cervical Cancer: A Case Report.

Zhang Y, Zhang J, Zhong M et al.

External validation of combining clinical parameters and urinary biomarker clusters and development of a nomogram for identifying bladder-centric interstitial cystitis/bladder pain syndrome in patients with lower urinary tract symptoms.

Tian JH, Yu WR, Jhang JF et al.

Impact of a Patient-Centered Chronic Pelvic Pain Toolkit on Patient Satisfaction: A Randomized Control Pilot Study.

Cosgriff L, Glowacki K, Morozov V et al.

Case Report: Neuropsychiatric improvement after treatment of pelvic venous disorder in a multisyndromic patient.

Smith SJ, Sichlau MJ, Rowe PC et al.

Functional bladder capacity can reflect the bladder condition and treatment outcome in patients with interstitial cystitis/bladder pain syndrome.

Yu WR, Kuo HC

Severe bilateral retinal degeneration following a twenty-six-year pentosan polysulfate sodium exposure: a case report.

Zhao AT, Wibbelsman TD, Calotti M et al.

Therapeutic efficacy of multimodal therapy for patients with interstitial cystitis/bladder pain syndrome refractory to previous bladder monotherapy.

Yu WR, Jhang JF, Jiang YH et al.

Bladder tumors in patients initially diagnosed with interstitial cystitis: a ten-year retrospective study.

Deng S, Jiang R, Wu S et al.

Efficacy and safety of pentosan polysulfate therapy in patients with interstitial cystitis for relief of lower urinary tract symptoms: 15-year single center experience.

Song SH, Song B, Jung G et al.

Successful treatment of chronic spontaneous urticaria and bladder pain syndrome with montelukast and/or omalizumab: a case report.

Bulut G

Role of psychosocial factors of symptom flares in a cohort of patients with urologic chronic pelvic pain syndrome: A cognitive-affective approach.

Lackner JM, Xiong Y, Rogers AH et al.

Association of specific HLA alleles in patients with interstitial cystitis suggesting autoimmunity.

Tabansky Stern I, Wang J, Moldwin RM et al.

Low-energy extracorporeal shock-wave therapy with or without intravesical botulinum toxin A instillations for refractory interstitial cystitis/bladder pain syndrome: a randomized double-blind trial of clinical and biomarker outcomes.

Jhang JF, Kuo HC

Editorial Comment on Long-Term Clinical Outcome of Transurethral Resection of Hunner Lesions Combined With Bladder Hydrodistention for Patients With Interstitial Cystitis at a Tertiary Center in Japan.

Kuo HC

Discrete mathematical network analysis bridging clinical vocabulary and patient discourse in interstitial cystitis/bladder pain syndrome online communications.

Okui N, Ichino K, Sakuma Y et al.

Imaging Mass Cytometry Immune Profiling of Hunner Lesions in a Convenience Sample of Patients With Interstitial Cystitis/Bladder Pain Syndrome.

Cotechini T, Kim N, Hindmarch CCT et al.

Effects of intravesical cocktail instillation on outcomes and serum pain factors of patients with bladder pain syndrome.

Jia Y, Zhang Y, Wang B et al.

Efficacy and Safety of Dupilumab in Adults with Prurigo Nodularis with or Without Atopic Comorbidities: A Subgroup Analysis from Two Randomized Phase III Clinical Trials.

Kim BS, Gonçalo M, Ugajin T et al.

Validation of the Italian Version of the O'Leary-Sant Questionnaire for Patients with Bladder Pain Syndrome/Interstitial Cystitis.

Natale F, Campagna G, Caramazza D et al.

The role of clinical nurse specialists in the management of patients with bladder pain syndrome.

Hillery S

Quality of patient information on interstitial cystitis from artificial intelligence chatbots.

Santucci J, Stapleton P, Ibrahim J et al.

Treatment Outcomes of Patients With Hunner Interstitial Cystitis Who Received Augmentation Enterocystoplasty or Bladder-Preserving Therapy.

Lee YS, Chang TL, Chen SF et al.

Efficacy and Safety of Submucosal Intravesical Injection of Platelet-Rich Plasma in the Treatment of Interstitial Cystitis/Painful Bladder Syndrome.

Mourad MS, Tawfick A, Kotb M et al.

Pigmentary Maculopathy in Patients with Interstitial Cystitis: Association with Pentosan Polysulfate and Other Therapies.

Qin S, Evans JK, Jeong C et al.

Long-Term Clinical Outcomes of Transurethral Resection of Hunner Lesions Combined With Bladder Hydrodistension for Patients With Interstitial Cystitis at a Tertiary Referral Center in Japan.

Akiyama Y, Hashimoto K, Niimi A et al.

Systemic ozone therapy improves the quality of life in patients with bladder pain syndrome.

Martinelli M, Glielmo A, Licci MR et al.

Metachronous Bilateral Nephrectomy, Supratrigonal Cystectomy, and Living Donor Renal Transplantation in a Patient With Chronic Kidney Disease due to Interstitial Cystitis and Total Urethral Stricture.

Sholan R, Aliyev R, Almazkhanli A et al.

Application study of pressure- and volume-controllable balloon in direct visualisation interstitial cystitis dilation surgery.

Wei W, Gao C, Wang H et al.

Long-term functional outcomes and complications of robot-assisted laparoscopic supratrigonal cystectomy with augmentation cystoplasty in adult patients with neurogenic lower urinary tract dysfunction and interstitial cystitis/bladder pain syndrome: A single-centre experience.

Batard T, Mesnard B, Levesque A et al.

Navigating the decision landscape: understanding interstitial cystitis/bladder pain syndrome patients' motivations and medical support needs for fecal microbiota transplantation: a qualitative research.

Liu H, Wei Y, Jiang P et al.

Camrelizumab plus SOX chemotherapy as adjuvant therapy for pathological stage III gastric or gastroesophageal junction adenocarcinoma: a prospective, multicenter, single-arm, phase II trial.

Jin H, Yu J, Gao Y et al.

Association of HRQOL With Symptom Patterns in an Online Cohort of Patients With Interstitial Cystitis/Bladder Pain Syndrome.

Galvez A, Kuhlmann P, Barker M et al.

Patient Related Outcomes for Interstitial Cystitis/Bladder Pain Syndrome Recommendations for Clinical Trials and General Urology Practice.

Hayes B, Namugosa M, Evans RJ et al.

Interstitial Cystitis/Bladder Pain Syndrome: Why a Global Patient Registry Is Critically Needed.

Mezes C, Niimi A, Kasyan G et al.

Interstitial Cystitis/Bladder Pain Syndrome Patient Phenotyping.

Wolff DT, Tranchina S, Schrepf A et al.

Carry-over effects in GAG therapy efficacy trial solution for bladder pain syndrome/interstitial cystitis (GETSBI study): an interim analysis.

van Ginkel C, Groenewoud JMM, Hoogeboom TJ et al.

Variability in Health Care Utilization and Perioperative Outcomes Among Urinary Diversion Patients: Analysis of the National Surgical Quality Improvement Program Database.

Fadel A, Findlay BL, Pinkhasov AM et al.

Widespread Pain Moderates the Response to Centrally-Acting Therapies in an Observational Cohort of Patients With Urologic Chronic Pelvic Pain Syndrome: A MAPP Research Network Study.

Schrepf A, Locke K, Moldwin R et al.

Intravesical injection of peripheral blood mononuclear cell for the treatment of interstitial cystitis: A preliminary report.

Tsai CP, Cheng KL, Yang E et al.

A single-center, phase 1/2a trial of hESC-derived mesenchymal stem cells (MR-MC-01) for safety and efficacy in interstitial cystitis patients.

Kyung YS, Hong KS, Chung HM et al.

Correction to "Clinical Manifestations of Interstitial Cystitis and Bladder Pain Syndrome: Analysis of a Patient Registry in Japan".

Late Development of Clinically Apparent Pentosan Polysulfate Maculopathy after Drug Cessation.

N'jai B, Rajagopalan A, Milner D et al.

Effectiveness of CO(2) micro-ablative vaginal laser therapy in the treatment of recurrent cystitis.

Filippini M, Sozzi J

Impact of Intravesical Chondroitin Sulfate Instillation on Sexual Function in Women with Interstitial Cystitis/Bladder Pain Syndrome.

Uçar M, Topcuoğlu M, Akkoç A et al.

Bacteriuria After Diagnostic Flexible Cystoscopy Without Antibiotic Prophylaxis: A Prospective Study.

Lo TS, Li CW, Ro AL et al.

Exploring the mechanism of Bazheng San on rats with Interstitial Cystitis/Bladder Pain Syndrome (IC/BPS) based on TLR4/NF-κB/NLRP3 signaling pathway.

Wenjie Y, Xin J, Yang L et al.

Gender Disparities in Procedural Management of Hunner Lesion Interstitial Cystitis.

Sze C, Fernandez CM, LaFrance M et al.

Treatment-Specific Clinical and Urinary Biomarker Signatures Associated With Response to Intravesical Botulinum Toxin A and Platelet-Rich Plasma in Bladder Pain Syndrome.

Yu WR, Hsieh TC, Wu YH et al.

A Survey on Real-World Transurethral Surgery Procedures for Bladder Pain Syndrome and Interstitial Cystitis.

Aya N, Yoshiyuki A, Akira F et al.

Metabotropic glutamate receptor 5 expression associates with pain and inflammatory pathways in interstitial cystitis.

Kwak Y, Kim B, Seok J et al.